- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-1440
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Practical considerations for the use of mTOR inhibitors ; volume:4 ; number:1 ; day:22 ; month:12 ; year:2015 ; pages:13-17 ; date:12.2015
Transplantation research ; 4, Heft 1 (22.12.2015), 13-17, 12.2015
- Urheber
-
Diekmann, Fritz
- Beteiligte Personen und Organisationen
-
Campistol, Josep M.
SpringerLink (Online service)
- DOI
-
10.1186/s13737-015-0029-5
- URN
-
urn:nbn:de:1111-2017030910174
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Diekmann, Fritz
- Campistol, Josep M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Practical considerations in computer based testing
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Clinical development of mTOR inhibitors in breast cancer
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Emergency Use Authorization for COVID-19 Vaccines and Practical Considerations for the Future
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Practical considerations in computer based testing
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Clinical development of mTOR inhibitors in breast cancer
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Emergency Use Authorization for COVID-19 Vaccines and Practical Considerations for the Future
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Practical considerations in computer based testing
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Clinical development of mTOR inhibitors in breast cancer
Perfect match: mTOR inhibitors and tuberous sclerosis complex